GENE ONLINE|News &
Opinion
Blog

Gilead Sciences
Taiwan’s Action Strategies Provide Great Model to Fight Coronavirus
2020-03-16
COVID-19 Victims on Remdesivir Treatment Hopeful after First US Patient Recovers
2020-03-12
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
Fight against COVID-19 Strengthens as Gilead Launches Phase III Trial for Remdesivir
2020-02-28
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
Update On 2019 Novel Coronavirus (2019-nCov): The Latest Progress In Vaccine Development And Treatment
2020-01-30
The 38th Annual J.P. Morgan Healthcare Conference – What to Expect?
2020-01-13
Weekly in Asia|Dec-3
2020-01-02
HIV
Weekly in Asia 2019|AUG-1
2019-08-17
Weekly in Asia 20190602-0608
2019-06-11
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
1 2 3 4
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!